AstraZeneca expanding R&D pipeline in China
- Posted on October 14, 2024
- By The China Daily
- 2 Views
AstraZeneca expanding R&D pipeline in China
In an interview with China Daily, Sharon Barr, executive vice-president of biopharmaceuticals R&D at AstraZeneca, said the company's presence in Shanghai is absolutely critical to achieving its bold ambition to be a pioneer in science and to create transformative new medicines for patients.
